Data from Pharmawand - Curated by EPG Health - Date added 28 June 2019
The ESMO World congress on Gastrointestinal cancer will be held in Barcelona, Spain, from 3rd to 6th July 2019.
In addition to key study details including FOLRIRI/FOLFOX and REARRANGE, the event will present the following press releases:
- Greater awareness needed of stomach cancer risk in under-40s, especially in Latin America (Abstract P-145), under embargo until Tuesday, 2 July 2019 at 8:00 CEST
- Randomised trial identifies optimal regimen of total neoadjuvant therapy for rectal cancer (Abstract O 011), under embargo until Thursday, 4 July 2019 at 9:30 CEST
- Targeted therapy combination improves survival in patients with advanced bowel cancer (Abstract LBA 006), under embargo until Saturday, 6 July 2019 at 11:00
- New trial demonstrates the efficacy of a more flexible dose of regorafenib to relieve side-effects in patients with metastatic colon cancer (Abstract O-026), under embargo until Saturday, 6 July 2019 at 11:00 CEST
Visit our sponsored learning zones:
Inflammatory Bowel Disease – detailing Crohn’s disease and ulcerative colitis, with video presentation filmed at Digestive Disease Week (DDW), Annual Congress of the European Crohn’s and Colitis Organisation (ECCO) and the United European Gastroenterology.
Anti-integrins in Inflammatory Bowel Disease – Highlighting two symposia presented at ECCO 2019: ‘Evolving Models of Care in Crohn's Disease - Identifying and Treating Patients at Risk of Disease Progression’ and ‘Treatment Decisions with Advanced Therapies: Comparative Evidence in Ulcerative Colitis’.
Inflammatory Bowel Disease Assessment Tools - Can the introduction of novel Inflammatory Bowel Disease (IBD) assessment tools that provide a measure of overall disease severity change how we manage IBD and improve patient outcomes? Watch the lively exchange between some of the leading experts in gastroenterology and IBD - Silvio Danese, Walter Reinisch and Stefan Schreiber - in this Sandoz-sponsored educational symposium recorded on 21 October 2018.